Longevity Tech Fund News Today

The wealthy are betting on 3D printed organs, AI-fueled drug discovery, and longevity VC funds. The biggest hurdle: telling the scientists from snake oil salesmen.

The wealthy are betting on 3D printed organs, AI-fueled drug discovery, and longevity VC funds. The biggest hurdle: telling the scientists from snake oil salesmen.

The wealthy are betting on 3D printed organs, AI-fueled drug discovery, and longevity VC funds. The biggest hurdle: telling the scientists from snake oil salesmen.

The public offering is on track to be a smaller exit for SoftBank than what a NVIDIA acquisition would have offered.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Rejuvenation Technologies, a biotechnology company developing mRNA-based therapeutics to address mechanisms of aging, today announced a $10.6M seed financing round led by Khosla Ventures. Shanda Ventures, Asymmetry Ventures, Merchant Adventures, Longevity Tech Fund, and Y Comb...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

University of Exeter spin-out SENISCA has raised more than £2 million from existing investors, to take its cell rejuvenation technology to the next stage of development. Click to read more...

A company borne out of University of Exeter research has raised more than £2 million from existing investors, to take its cell rejuvenation technology to aid healthy ageing to the next stage of development.SENISCA has developed a technology to combat